Medical Devices
Vensana Capital Strengthens Team with Key Appointments in Medical Technology Investment
Vensana Capital enhances its leadership team by appointing Maria Berkman as Partner and Ross (Rusty) Segan as Venture Partner, signaling a strategic move to bolster its expertise in medical technology investments.
Nutriband Inc.'s AVERSA Technology Poised for FDA Approval with Significant Market Potential
Nutriband Inc.'s innovative AVERSA abuse-deterrent patch technology, targeting the misuse of transdermal patches like fentanyl, is on its way to FDA approval, with an estimated annual market potential of $800 million.
Lorati Unveils NanoClay Paste: A Natural Revolution in Wound Care
Lorati Company Limited introduces NanoClay Paste, a natural, mineral-based treatment offering fast and effective healing for chronic wounds and skin infections, marking a significant advancement in non-invasive medical solutions.
Inspira Technologies Receives Buy Rating with $2 Price Target, Signaling Major Medical Technology Breakthrough
Litchfield Hills Research initiated coverage of Inspira Technologies with a Buy rating and $2 price target, highlighting the company's innovative respiratory support technology that could revolutionize critical care treatment by offering an alternative to traditional mechanical ventilation.
Neuroscientists Develop RADICAL: A Breakthrough Tool for Precise Neural Control
Researchers have engineered a novel chemogenetic tool called RADICAL that enables non-invasive, precise manipulation of brain activity using a synthetic chemical, offering significant potential for neuroscience research and therapeutic interventions.
AI-Powered Exoskeleton Restores Mobility for Wheelchair Users
A new AI-driven exoskeleton technology is transforming the lives of individuals with mobility impairments, offering unprecedented freedom and social interaction for wheelchair users through advanced technological innovation.
Glucotrack Unveils Revolutionary Continuous Blood Glucose Monitor Technology at Upcoming Webinar
Glucotrack is set to showcase its innovative Continuous Blood Glucose Monitor (CBGM) technology, offering a potential breakthrough in diabetes management with longer-lasting, real-time monitoring capabilities.
Innovative Swallowable Pill Promises Real-Time Gut Health Monitoring
A new medical technology offers groundbreaking potential for tracking gut inflammation in real-time through a swallowable pill, which could revolutionize diagnostic approaches for gastrointestinal disorders.
Nutriband Seeks to Revolutionize Transdermal Pain Management Through Innovative Abuse-Deterrent Technology
Nutriband is developing a groundbreaking transdermal drug delivery platform aimed at addressing pain management challenges in the wake of the opioid crisis, focusing on creating safer, more accessible opioid therapies.
Intelligent Bio Solutions Advances Non-Invasive Drug Testing Technology for U.S. Market
Intelligent Bio Solutions is progressing toward FDA clearance for a groundbreaking fingerprint-based drug screening system with 94.1% accuracy, positioning the company for potential expansion across safety-critical industries in the United States.
Nutriband Advances Opioid Patch Technology with Potential Abuse-Deterrent Solution
Nutriband is making significant progress toward commercializing its AVERSA Fentanyl technology, partnering with Kindeva Drug Delivery to develop a potentially groundbreaking opioid pain patch with abuse-deterrent properties.
SeaStar Medical Advances Organ-Saving Therapies for Critically Ill Patients
SeaStar Medical is developing innovative medical devices targeting acute kidney injury, leveraging FDA Breakthrough Device Status to potentially transform treatment for critically ill patients across multiple serious conditions.
Turner MedTech Expands Manufacturing Capabilities to Improve MRI Patient Positioning
Turner MedTech is scaling up manufacturing for its KyphoLift patient positioning system, addressing critical needs in medical imaging for patients with mobility challenges and complex spinal conditions. The expansion aims to enhance diagnostic precision and patient comfort in MRI procedures.
MDPen Launches Corrective Microneedling™: Advanced Skin Rejuvenation Technology
MDPen introduces a cutting-edge microneedling technique that creates up to 324,000 microchannels per minute, offering comprehensive skin rejuvenation solutions for practitioners and patients across multiple skin concerns.
Canadian Firms Unveil Rapid Drug Residue Detection Device to Enhance Public Safety
Kaimi Biotech and Scenesafe partner to introduce Unow™, a portable testing device capable of quickly identifying trace drug residues across multiple sectors in Canada. The technology aims to improve safety protocols in law enforcement, healthcare, and property management.
Nutriband Expands Pharma Footprint with Strategic Partnerships
Nutriband Inc. strengthens its market position through strategic alliances with Charlotte FC and Kindeva Drug Delivery, focusing on its innovative abuse-deterrent transdermal drug delivery technology.
HeartBeam Advances Cardiac Care Technology with FDA Milestone and Strategic Partnerships
Medical technology company HeartBeam achieved significant progress in Q1 2025, completing a pivotal study for its 12-lead ECG synthesis software and expanding strategic partnerships while raising crucial funding for commercialization.
Glucotrack Advances Continuous Blood Glucose Monitor with First Human Trial Success
Glucotrack has completed a groundbreaking first-in-human study of its intravascular continuous blood glucose monitor, demonstrating safety and technical feasibility for insulin-dependent diabetes patients. The successful trial paves the way for a comprehensive long-term clinical evaluation.
Nutriband Develops Innovative Abuse-Deterrent Fentanyl Patch to Address Opioid Crisis
Nutriband Inc. has developed AVERSA™ Fentanyl, a technologically advanced transdermal patch designed to provide effective pain management while mitigating potential opioid abuse risks. The innovation represents a strategic approach to addressing the ongoing public health challenge of the opioid epidemic.
SeaStar Medical Achieves Six FDA Breakthrough Device Designations, Promising New Hope for Critical Care Patients
SeaStar Medical has secured six FDA Breakthrough Device Designations for its Selective Cytopheretic Device (SCD) therapy, targeting life-threatening conditions with limited treatment options. These designations highlight the potential to transform care for patients with acute kidney injury, inflammatory responses, and other critical health challenges.
Femto Technologies Secures Patent Allowance for Innovative Sensera Wellness Device
Femto Technologies Inc. received a Notice of Allowance from the USPTO for its Sensera device design, highlighting a significant milestone in AI-driven female wellness technology that was recently honored with a CES Innovation Award.
SeaStar Medical Advances Kidney Injury Treatment with Innovative Pediatric Therapy
SeaStar Medical's QUELIMMUNE therapy offers promising treatment for pediatric acute kidney injury, with FDA approval and early hospital adoption signaling potential breakthrough in a critical healthcare challenge.
Nutriband Advances Abuse-Deterrent Fentanyl Patch in Response to Opioid Crisis
Nutriband is developing an innovative abuse-deterrent transdermal fentanyl patch amid shifting FDA regulations and ongoing efforts to combat opioid misuse. The technology represents a potential breakthrough in safer pain management strategies.
Hydromer Reports Q1 Revenue Decline Amid Strategic Reinvestment
Medical coatings company Hydromer experienced a revenue and earnings decrease in Q1 2025, yet remains committed to strategic investments and long-term growth in the medical device technology sector.
Femto Technologies Secures Patent for Smart Release System Technology in Femtech Innovation
Femto Technologies has received a Notice of Allowance from the U.S. Patent and Trademark Office for its proprietary Smart Release System technology, reinforcing its position as an AI-driven feminine wellness innovator and highlighting the potential for advanced technology in personal health solutions.
HeartBeam Expands Patent Portfolio with Innovative Cardiac Monitoring Technologies
Medical technology company HeartBeam adds two new U.S. patents to its intellectual property collection, enhancing its capabilities in portable cardiac monitoring and arrhythmia detection technology.
HeartBeam Expands Board with CEO Robert Eno's Appointment
HeartBeam Inc. strengthens its leadership by appointing CEO Robert Eno to its Board of Directors, signaling strategic preparation for the commercial launch of its innovative 3D ECG technology.
HeartBeam to Host Q1 2025 Financial Results Conference Call, Spotlight Cardiac Innovation
Medical technology company HeartBeam will provide a comprehensive business update and first-quarter financial results, highlighting its potential to revolutionize cardiac health monitoring through innovative portable diagnostic technology.
United Health Products Faces FDA Hurdle in Medical Device Approval Process
United Health Products navigates regulatory challenges while achieving OTCQB market uplisting, signaling potential strategic shifts in its medical technology development efforts.
Monogram Technologies Receives Indian Regulatory Approval for Robotic Knee Surgery Clinical Trial
Monogram Technologies has secured regulatory approval to conduct a multi-center clinical trial in India for its mBôs TKA robotic total knee replacement system, marking a significant step toward potential commercial launch and advancement in orthopedic surgical technology.